AFT Pharmaceuticals Ltd. (AU:AFP) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
AFT Pharmaceuticals Ltd. has released its interim report for the first half of 2024, highlighting its operational and financial performance up to September 30. The report underscores the company’s commitment to transparency and accuracy, with financials reviewed by Deloitte Limited, aligning with corporate governance standards. Investors are encouraged to review the detailed financial statements for a comprehensive understanding.
For further insights into AU:AFP stock, check out TipRanks’ Stock Analysis page.